These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11513800)

  • 1. Programmable fusogenic vesicles for intracellular delivery of antisense oligodeoxynucleotides: enhanced cellular uptake and biological effects.
    Hu Q; Shew CR; Bally MB; Madden TD
    Biochim Biophys Acta; 2001 Sep; 1514(1):1-13. PubMed ID: 11513800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcellular trafficking of antisense oligonucleotides and down-regulation of bcl-2 gene expression in human melanoma cells using a fusogenic liposome delivery system.
    Hu Q; Bally MB; Madden TD
    Nucleic Acids Res; 2002 Aug; 30(16):3632-41. PubMed ID: 12177306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lipid-based delivery system for antisense oligonucleotides derived from a hydrophobic complex.
    Wong FM; MacAdam SA; Kim A; Oja C; Ramsay EC; Bally MB
    J Drug Target; 2002 Dec; 10(8):615-23. PubMed ID: 12683666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
    J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.
    Williams SA; Chang L; Buzby JS; Suen Y; Cairo MS
    Leukemia; 1996 Dec; 10(12):1980-9. PubMed ID: 8946941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal delivery of antisense oligonucleotides for efficient downregulation of Bcl-2 and induction of apoptosis.
    Buck AC; Shen C; Schirrmeister H; Schmid-Kotsas A; Munzert G; Guhlmann A; Mehrke G; Klug N; Gross HJ; Bachem M; Reske SN
    Cancer Biother Radiopharm; 2002 Jun; 17(3):281-9. PubMed ID: 12136520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
    Zupi G; Scarsella M; Semple SC; Mottolese M; Natali PG; Leonetti C
    Clin Cancer Res; 2005 Mar; 11(5):1990-8. PubMed ID: 15756025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligodeoxynucleotides to bax mRNA promote survival of rat sympathetic neurons in culture.
    Gillardon F; Zimmermann M; Uhlmann E; Krajewski S; Reed JC; Klimaschewski L
    J Neurosci Res; 1996 Mar; 43(6):726-34. PubMed ID: 8984202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence.
    Ziegler A; Luedke GH; Fabbro D; Altmann KH; Stahel RA; Zangemeister-Wittke U
    J Natl Cancer Inst; 1997 Jul; 89(14):1027-36. PubMed ID: 9230884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes.
    Mathew E; Hardee GE; Bennett CF; Lee KD
    Gene Ther; 2003 Jul; 10(13):1105-15. PubMed ID: 12808441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition of human leukemia HL-60 cells by an antisense phosphodiester oligonucleotide encapsulated into fusogenic liposomes.
    Kondoh M; Matsuyama T; Suzuki R; Mizuguchi H; Nakanishi T; Nakagawa S; Tsutsumi Y; Nakanishi M; Sato M; Mayumi T
    Biol Pharm Bull; 2000 Aug; 23(8):1011-3. PubMed ID: 10963315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery to cancer cells of antisense L-myc oligonucleotides incorporated in fusogenic, cationic-lipid-reconstituted influenza-virus envelopes (cationic virosomes).
    Waelti ER; Glück R
    Int J Cancer; 1998 Aug; 77(5):728-33. PubMed ID: 9688306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposome-coated lipoplex-based carrier for antisense oligonucleotides.
    Wyrozumska P; Meissner J; Toporkiewicz M; Szarawarska M; Kuliczkowski K; Ugorski M; Walasek MA; Sikorski AF
    Cancer Biol Ther; 2015; 16(1):66-76. PubMed ID: 25482931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-proliferative effects of unmodified antisense oligodeoxynucleotides targeted against c-raf mRNA: use of poly (lysine/serine) copolymers or cationic lipopolyamines.
    Aoki Y; Kawa S; Karasawa Y; Horiuchi A; Kiyosawa K
    Clin Exp Pharmacol Physiol; 1998 Sep; 25(9):702-5. PubMed ID: 9750959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the intracellular delivery and molecular efficacy of antisense oligonucleotides in chronic myeloid leukemia cells: a comparison of streptolysin-O permeabilization, electroporation, and lipophilic conjugation.
    Spiller DG; Giles RV; Grzybowski J; Tidd DM; Clark RE
    Blood; 1998 Jun; 91(12):4738-46. PubMed ID: 9616172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of cellular functions in retroorbital fibroblasts using antisense oligonucleotides targeting the c-myc protooncogene.
    Heufelder AE; Bahn RS
    Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1420-32. PubMed ID: 7775120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific inhibition of influenza virus RNA polymerase and nucleoprotein gene expression by liposomally encapsulated antisense phosphorothioate oligonucleotides in MDCK cells.
    Abe T; Suzuki S; Hatta T; Takai K; Yokota T; Takaku H
    Antivir Chem Chemother; 1998 May; 9(3):253-62. PubMed ID: 9875404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides.
    Morishita R; Gibbons GH; Ellison KE; Nakajima M; von der Leyen H; Zhang L; Kaneda Y; Ogihara T; Dzau VJ
    J Clin Invest; 1994 Apr; 93(4):1458-64. PubMed ID: 8163650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel intracellular delivery system of antisense oligonucleotide by self-assembled hybrid micelles composed of DNA/PEG conjugate and cationic fusogenic peptide.
    Jeong JH; Kim SW; Park TG
    Bioconjug Chem; 2003; 14(2):473-9. PubMed ID: 12643759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity.
    Adlakha-Hutcheon G; Bally MB; Shew CR; Madden TD
    Nat Biotechnol; 1999 Aug; 17(8):775-9. PubMed ID: 10429242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.